Pharmacological treatment with cabergoline in three cats with acromegaly
Soler-Arias, Elber A; García, Jorge D; Castillo, Víctor A.
Rev. colomb. cienc. pecu
; 30(4): 316-321, oct.-dic. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-900629
Documentos relacionados
Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus.
Acromegaly in humans and cats: Pathophysiological, clinical and management resemblances and differences.
Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism.
Platinossomose em felino doméstico no município de Pelotas, RS, Brasil
Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats.
Effect of Cabergoline Treatment on Disease Control in Acromegaly Patients.
The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly.
Feline Comorbidities: Hypersomatotropism-induced diabetes in cats.
Exogenous insulin treatment after hypofractionated radiotherapy in cats with diabetes mellitus and acromegaly.